Scinai Immunotherapeutics Ltd. (SCNI) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Total Current Assets | 3.61M | 1.51M | 1.51M | 2.39M | 1.62M | 3.66M | 5.25M | 5.45M | 6.71M | 7.77M | 11.04M | 14.37M | 8.46M | 11.47M | 15.47M | 17.84M | 11.2M | 13.04M | 14.67M | 3.31M |
| Cash & Short-Term Investments | 3.11M | 989K | 989K | 1.96M | 1.03M | 3.08M | 4.83M | 4.87M | 6.36M | 7.51M | 10.8M | 14.07M | 8.26M | 11.29M | 15.28M | 17.37M | 10.75M | 12.23M | 14.53M | 2.93M |
| Cash Only | 3.11M | 989K | 989K | 1.96M | 1.03M | 3.08M | 4.83M | 4.87M | 6.36M | 7.51M | 10.8M | 14.07M | 8.26M | 11.29M | 15.28M | 17.37M | 10.75M | 12.23M | 14.53M | 2.93M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 150K | 139K | 139K | 217K | 120K | 119K | 288K | 366K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | 27.04 | 32.73 | 41.45 | 75.25 | 65.44 | 65.21 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 350K | 142K | 142K | 131K | 465K | 138K | -148K | 140K | 122K | 126K | 127K | 250K | 199.95K | 178.99K | 193.49K | 241K | 442.29K | 810K | 143.85K | 71.25K |
| Total Non-Current Assets | 13.97M | 10.33M | 10.33M | 11.06M | 10.64M | 11.19M | 11.8M | 12.03M | 11.87M | 12.13M | 12.25M | 12.7M | 12.5M | 12.99M | 14.39M | 14.19M | 13.93M | 13.96M | 13.66M | 14.4M |
| Property, Plant & Equipment | 13.97M | 10.33M | 10.33M | 11.06M | 10.64M | 11.19M | 11.8M | 12.03M | 11.87M | 12.13M | 12.25M | 12.7M | 12.22M | 12.72M | 14.1M | 14.19M | 13.8M | 13.83M | 13.53M | 14.25M |
| Fixed Asset Turnover | 0.04x | 0.04x | 0.04x | 0.02x | 0.02x | 0.02x | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 271.46K | 277.06K | 290.38K | 0 | 138.33K | 134.03K | 130.39K | 147.16K |
| Total Assets | 17.59M | 11.84M | 11.84M | 13.45M | 12.26M | 14.85M | 17.05M | 17.47M | 18.58M | 19.9M | 23.29M | 27.07M | 20.95M | 24.47M | 29.86M | 32.04M | 25.13M | 27M | 28.33M | 17.71M |
| Asset Turnover | 0.03x | 0.03x | 0.03x | 0.02x | 0.01x | 0.02x | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 48.55% | -20.27% | -30.56% | -23.03% | -34.02% | -25.36% | -26.79% | -35.45% | -11.32% | -18.68% | -22% | -15.51% | -16.62% | -9.4% | 5.42% | 80.93% | 14.93% | 9.17% | - | -47.17% |
| Total Current Liabilities | 2.69M | 2.12M | 2.12M | 1.81M | 1.39M | 1.67M | 1.93M | 1.78M | 1.54M | 1.89M | 2.58M | 2.34M | 1.47M | 6.72M | 2.66M | 2.44M | 21.8M | 21.28M | 19.95M | 19.97M |
| Accounts Payable | 779.01K | 659K | 659K | 376K | 430K | 658K | 928K | 535K | 546K | 651K | 1.31M | 716K | 295.58K | 588.13K | 1.28M | 999K | 1.03M | 808.16K | 623.54K | 581.19K |
| Days Payables Outstanding | 40.94 | 58.71 | 45.59 | 99.4 | 120.02 | 161.08 | 422.03 | 585.63 | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 354K | 0 | 0 | 0 | 0 | 0 | 387K | 396K | 0 | 0 | 0 | 0 | 242.01K | 5.35M | 0 | 0 | 20M | 19.7M | 18.65M | 18.8M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 225K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.55M | 964K | 964K | 0 | 0 | 650K | -387K | -396K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 0 |
| Current Ratio | 1.35x | 0.71x | 0.71x | 1.32x | 1.16x | 2.19x | 2.73x | 3.06x | 4.36x | 4.12x | 4.28x | 6.15x | 5.75x | 1.71x | 5.82x | 7.30x | 0.51x | 0.61x | 0.74x | 0.17x |
| Quick Ratio | 1.35x | 0.71x | 0.71x | 1.32x | 1.16x | 2.19x | 2.73x | 3.06x | 4.36x | 4.12x | 4.28x | 6.15x | 5.75x | 1.71x | 5.82x | 7.30x | 0.51x | 0.61x | 0.74x | 0.17x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 3.14M | 1.86M | 1.86M | 1.67M | 866K | 20.46M | 20.24M | 20.26M | 19.74M | 25.12M | 25.52M | 26.49M | 16.86M | 16.46M | 22.15M | 28.61M | 2.04M | 2.23M | 2.16M | 2.28M |
| Long-Term Debt | 287K | 293K | 293K | 260K | 280K | 19.82M | 19.51M | 19.37M | 18.6M | 23.29M | 21.85M | 20.08M | 15.53M | 14.85M | 20.38M | 27.16M | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 2.86M | 1.57M | 1.57M | 1.4M | 583K | 640K | 732K | 797K | 823K | 927K | 1.01M | 1.08M | 1.3M | 1.58M | 1.75M | 1.45M | 1.83M | 1.85M | 1.79M | 1.89M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 3K | 3K | 3K | 3K | 3K | 0 | 96K | 311K | 902K | 2.66M | 5.33M | 26.64K | 27.16K | 29.7K | 30.52K | 205.64K | 377.24K | 367.85K | 382.69K |
| Total Liabilities | 5.83M | 3.98M | 3.98M | 3.47M | 2.26M | 22.14M | 22.17M | 22.04M | 21.27M | 27.01M | 28.1M | 28.83M | 18.33M | 23.19M | 24.81M | 31.05M | 23.83M | 23.51M | 22.11M | 22.25M |
| Total Debt | 3.5M | 2.36M | 2.36M | 2.09M | 1.23M | 20.82M | 20.63M | 20.56M | 19.81M | 24.61M | 23.28M | 21.54M | 17.39M | 22.03M | 22.37M | 28.98M | 22.07M | 21.79M | 20.62M | 20.9M |
| Net Debt | 382K | 1.37M | 1.37M | 122K | 195K | 17.75M | 15.8M | 15.69M | 13.45M | 17.11M | 12.48M | 7.47M | 9.14M | 10.74M | 7.09M | 11.61M | 11.32M | 9.56M | 6.1M | 17.97M |
| Debt / Equity | 0.30x | 0.30x | 0.30x | 0.21x | 0.12x | - | - | - | - | - | - | - | 6.63x | 17.25x | 4.43x | 29.52x | 17.00x | 6.24x | 3.31x | - |
| Debt / EBITDA | - | - | - | - | - | 4.68x | - | - | - | 2.70x | - | 4.83x | 13.36x | - | - | 3.68x | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | 3.99x | - | - | - | 1.88x | - | 1.67x | 7.02x | - | - | 1.48x | - | - | - | - |
| Interest Coverage | -22.03x | -10.14x | -109.03x | -58.54x | 6.55x | -6.90x | -8.25x | -3.56x | - | -2.25x | -9.78x | - | - | -17.26x | -10.94x | -3.69x | -2.95x | -3.26x | -2.53x | -16.27x |
| Total Equity | 11.76M | 7.86M | 7.86M | 9.98M | 10M | -7.28M | -5.12M | -4.57M | -2.69M | -7.11M | -4.81M | -1.76M | 2.62M | 1.28M | 5.05M | 982K | 1.3M | 3.49M | 6.22M | -4.54M |
| Equity Growth % | 49.67% | 207.88% | 253.6% | 318.36% | 471.58% | -2.42% | -6.36% | -159.6% | -202.57% | -656.72% | -195.17% | -279.23% | 102.15% | -63.42% | -18.77% | 121.62% | 341.62% | 119.54% | 133.93% | 75.89% |
| Book Value per Share | 12432.49 | 4.94 | 9.74 | 12.37 | 11.86 | -11.42 | -10.10 | -15.21 | -5.74 | -21.04 | -14.85 | -9.06 | 14.05 | 6.84 | 27.15 | 6.77 | 9.06 | 24.37 | 46.88 | -39.41 |
| Total Shareholders' Equity | 11.76M | 7.86M | 7.86M | 9.98M | 10M | -7.28M | -5.12M | -4.57M | -2.69M | -7.11M | -4.81M | -1.76M | 2.62M | 1.28M | 5.05M | 982K | 1.3M | 3.49M | 6.22M | -4.54M |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -122.27M | -121.67M | -121.67M | -117.54M | -115.31M | -126.82M | -124.49M | -122.33M | -120M | -123.11M | -119.35M | -115.83M | -107.49M | -110.66M | -116.96M | -110.04M | -109.8M | -105.8M | -99.58M | -101.05M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -1.74M | -1.74M | -1.74M | -1.74M | -1.74M | -1.74M | -1.74M | -1.74M | -1.74M | -1.74M | -1.89M | -2.01M | 0 | 0 | 0 | -2.06M | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |